Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis

Main Article Content

CEM Griffiths
KA Papp
M Song
B Randazzo
S Li
YK Shen
C Han
A Blauvelt

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Janssen.

 

Copyright 2018 SKIN